Governance Grifols, S.A.

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME Other stock markets 16:35:11 06/02/2026 GMT			5-day change	1st Jan Change
10.87 ^EUR	+0.28%		+0.74%	+1.59%

02-05	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading	MT
01-21	European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	MT

Executive Committee: Grifols, S.A.

Manager

Positions heldSince

Nacho Abia

57 year

Chief Executive Officer

31/03/2024

Fernando Sebastian Rodriguez Haro

47 year

Comptroller/Controller/Auditor

31/12/2015

David Bell

72 year

General Counsel

30/06/2003

Nuria Martín Barnés

67 year

Corporate Secretary

28/05/2015

Jörg Schüttrumpf

52 year

Chief Tech/Sci/R&D Officer

31/08/2024

Composition of the Board of Directors: Grifols, S.A.

Director

CommitteesSince

Anne-Catherine Berner

62 year

Compensation Committee	31/12/2018
HR Committee	31/12/2018

Paul Herendeen

70 year

Audit Committee
Finance Committee Chair	15/05/2025
Compensation Committee	07/12/2024
Nominating Committee	07/12/2024

Montserrat Muñoz Abellana

58 year

Audit Committee	15/07/2024
Compensation Committee Chair
Nominating Committee Chair

Victor Grifols Deu

50 year

Compensation Committee
Nominating Committee

Tomás Dagá Gelabert

70 year

Compensation Committee	24/01/2010
Nominating Committee	24/01/2010

Susana González Rodríguez

49 year

Compensation Committee	09/06/2022
Nominating Committee	09/06/2022

Íñigo Sánchez-Asiaín Mardones

61 year

Audit Committee Chair

Pascal Ravery

69 year

Audit Committee

07/12/2024

Raimon Grifols Roura

63 year

Director/Board Member

23/05/2015

Enriqueta Felip Font

61 year

Director/Board Member	23/05/2019
Independent Dir/Board Member	23/05/2019

Albert Coma-Cros

48 year

Director/Board Member

18/12/2023

Nacho Abia

57 year

Director/Board Member

25/02/2024

Víctor Grifols Roura

76 year

Director/Board Member

29/09/2022

Latest Appointments: Grifols, S.A.

01-08	Grifols, S.A. Announces Board Changes, Effective January 1, 2026	CI
28/05/25	Biotest AG Names New CEO	MT
22/05/25	Moody's Lifts Grifols' Ratings on Operating Performance Strength	MT
26/02/25	Grifols' Chairman to Step Down; Successor Named	MT
25/02/25	Grifols to Appoint Anne-Catherine Berner as Chair	MT
25/02/25	Grifols, S.A. Announces Board Changes	CI
25/02/25	Grifols Says Anne Catherine Berner To Succeed Thomas Glanzmann As Non-Executive Chairperson	RE

More news

Former Officers and Directors: Grifols, S.A.

Insider

Positions held

SinceUntil

Maria Teresa Rioné Llano

Public Communications Contact

31/12/2017

28/02/2025

James Costos

Director/Board Member	08/10/2020	18/09/2024
Independent Dir/Board Member	08/10/2020	18/09/2024

Alfredo Arroyo Guerra

Chief Administrative Officer	26/01/2010	29/05/2013
Director of Finance/CFO	31/12/2006	15/09/2024
Director of Research - Fxd Inc	26/01/2010	26/01/2010

Claire Giraut

Director/Board Member	13/06/2024	11/07/2024
Independent Dir/Board Member	13/06/2024	11/07/2024

Carina Szpilka Lázaro

Director/Board Member	28/05/2015	11/07/2024
Independent Dir/Board Member	28/05/2015	11/07/2024

Montserrat Gaja Llamas

Human Resources Officer

30/06/2021

30/04/2024

Marilyn Rosa-Bray

Chief Tech/Sci/R&D Officer	31/05/2022	10/07/2023
General Counsel	31/05/2022	10/07/2023

Xavier Sueiras Gil

Chief Tech/Sci/R&D Officer

31/12/2017

28/02/2023

Steven Mayer

Director/Board Member	20/02/2023	-
Chairman	02/10/2022	20/02/2023
Independent Dir/Board Member	24/01/2011	20/02/2023

Antonio Martínez Martínez

Chief Tech/Sci/R&D Officer

31/12/2019

30/06/2022

Belén Villalonga Morenés

Director/Board Member	23/05/2013	31/12/2021
Independent Dir/Board Member	23/05/2013	31/12/2021

Joseph Schachle

Corporate Officer/Principal

31/07/2017

31/08/2021

Mateo Florencio Borrás Humbert

Human Resources Officer

26/01/2010

31/05/2021

Luís Isasi Fernández de Bobadilla

Director/Board Member	24/05/2011	08/10/2020
Independent Dir/Board Member	23/05/2011	08/10/2020

Edgar Jannotta

Director/Board Member	24/01/2010	04/06/2015
Independent Dir/Board Member	01/06/2011	04/06/2015

Marla E. Salmon

Director/Board Member	29/05/2014	-
Independent Dir/Board Member	29/05/2014	-

Carsten Schroeder

Corporate Officer/Principal

31/12/2013

Brett Ingersoll

Director/Board Member	27/01/2011	-
Independent Dir/Board Member	24/01/2011	-

Lafmin Morgan

Corporate Officer/Principal

30/06/2018

Christian Purslow

Director/Board Member	26/01/2010	-
Independent Dir/Board Member	-	-

Anna Veiga Lluch

Director/Board Member	08/12/2008	-
Independent Dir/Board Member	08/12/2008	-

Eva Bastida Tubau

Chief Tech/Sci/R&D Officer	31/12/2006	-
Corporate Officer/Principal	21/02/2012	-

Thomas Heinrich Glanzmann

Director/Board Member	04/04/2006	20/02/2023
Chief Executive Officer	07/05/2023	31/03/2024
Chairman	20/02/2023	-

José Antonio Grifols Gras

Director/Board Member

19/01/2000

Nuria Pascual Lapeña

Director of Finance/CFO	31/12/1995	-
Investor Relations Contact	31/12/1995	-
Treasurer	-	-

Francisco Javier Jorba Ribes

Corporate Officer/Principal

31/12/1994

Montserrat Lloveras Calvo

Chief Administrative Officer	31/12/1990	-
Comptroller/Controller/Auditor	31/12/1990	-

Juan Ignacio Twose Roura

Director/Board Member	24/01/2010	-
Corporate Officer/Principal	28/01/2010	31/12/2013

Carlos Roura Fernandez

Corporate Officer/Principal

27/09/2010

Vicente Blanquer Torre

Chief Tech/Sci/R&D Officer	31/12/1986	-
General Counsel	31/12/2006	-
Corporate Officer/Principal	31/12/1986	-

Antonio Viñes Páres

Corporate Officer/Principal

27/09/2010

Ramón Riera Roca

Director/Board Member	31/03/2000	-
Corporate Officer/Principal	22/11/2010	21/02/2012
Sales & Marketing	26/01/2010	-

Javier Roura Fernandez

Director of Finance/CFO	26/01/2010	-
Corporate Officer/Principal	22/11/2010	21/02/2012

Christopher Hanna

Director/Board Member

Josep Antoni Grifols Roig

Founder

17/11/1940

Age distribution of managers

Parity Men Women

Male	14
Female	4

Of which Executive Committee

Male	4
Female	1

Of which Directors

Male	10
Female	3

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (85.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (3%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (2.9%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.9%), European Union (15.5%), the United States and Canada (56.7%) and other (21.9%).

Employees

23,800

Sector

Pharmaceuticals

Calendar

02-25 - Q4 2025 Earnings Release (Projected)

More about the company